CLINITEK ATLAS PRO 12 REAGENT PAK SYSTEM

Enzymatic Method, Creatinine

BAYER CORP.

The following data is part of a premarket notification filed by Bayer Corp. with the FDA for Clinitek Atlas Pro 12 Reagent Pak System.

Pre-market Notification Details

Device IDK021428
510k NumberK021428
Device Name:CLINITEK ATLAS PRO 12 REAGENT PAK SYSTEM
ClassificationEnzymatic Method, Creatinine
Applicant BAYER CORP. 511 BENEDICT AVE. Tarrytown,  NY  10591 -5097
ContactKenneth T Edds
CorrespondentKenneth T Edds
BAYER CORP. 511 BENEDICT AVE. Tarrytown,  NY  10591 -5097
Product CodeJFY  
Subsequent Product CodeCDM
Subsequent Product CodeCEN
Subsequent Product CodeJIL
Subsequent Product CodeJIN
Subsequent Product CodeJIP
Subsequent Product CodeJIR
Subsequent Product CodeJJB
Subsequent Product CodeJMT
Subsequent Product CodeJRE
Subsequent Product CodeKQO
Subsequent Product CodeLJX
CFR Regulation Number862.1225 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2002-05-03
Decision Date2002-07-05
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00630414479095 K021428 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.